Iron deficiency in the acute-phase reaction after open aortic surgery

Vascular and Endovascular Surgery

Volumn 40, Issue 5, 2006, Pages 392-398

  Solis, J V ^a   Portero, J L ^a   Diaz, J ^a   Garcia, R ^a   Ligero, J M ^a   Vazquez, E ^a   Lodeiro, C ^a   Ballesteros, L ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FERRITIN; FIBRINOGEN; HEMOGLOBIN; IRON; TRANSFERRIN; TRANSFERRIN RECEPTOR;

ACUTE PHASE RESPONSE; ADULT; AGED; ANALYSIS OF VARIANCE; AORTA SURGERY; ARTICLE; BLOOD SAMPLING; BLOOD TRANSFUSION; CONTROLLED STUDY; ERYTHROCYTE COUNT; FIBRINOGEN BLOOD LEVEL; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HUMAN; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON THERAPY; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; QUANTITATIVE DIAGNOSIS; TRANSFERRIN BLOOD LEVEL;

ACUTE-PHASE REACTION; AGED; AGED, 80 AND OVER; ANEMIA, IRON-DEFICIENCY; AORTA; AORTIC DISEASES; C-REACTIVE PROTEIN; ERYTHROCYTE COUNT; ERYTHROCYTE INDICES; FERRITINS; FIBRINOGEN; HEMATOCRIT; HEMOGLOBINS; HUMANS; IRON; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; RECEPTORS, TRANSFERRIN; RISK FACTORS; TIME FACTORS; TRANSFERRIN; VASCULAR SURGICAL PROCEDURES;

EID: 33750031792     PISSN: 15385744     EISSN: None     Source Type: Journal    
DOI: 10.1177/1538574406293749     Document Type: Article

References (44)

1. Hashmi S, Rogers SO: Current concepts in critical care. J Am Coll Surg 200:88-95, 2005.
2. Bone R: Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 24:1125-1128, 1996.
3. Trey JE, Kushner I: The acute-phase response and the hematopoietic system: The role of cytokines. Crit Rev Oncol Hematol 21:1-18, 1995.
4. Biesma DH, van de Weil A, Beguin Y, et al: Postoperative erythropoiesis is limited by the inflammatory effect of surgery on iron metabolism. Eur J Clin Invest 25:383-389, 1995.
5. Heinrich PC, Castell JV, Andus T: Interleukin-6 and the acute-phase response. Biochem J 265:621-636, 1990.
6. Aisen P: Transferrin receptor 1. Int J Biochem Cell Biol 36:2137-2143, 2004.
7. Boccio J, Salgueiro J, Lysionek A, et al: Current knowledge of iron metabolism. Biol Trace Element Res 92:189-211, 2003.
8. Beris P: The use of iron to increase red cell mass. Can J Anesth 50:S3-9, 2003.
9. Kumpf VJ: Update on parenteral iron therapy. Nutr Clin Pract 18:318-326, 2003.
10. Ridker PM, Buring JE, Cook NR, et al: C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. Circulation 107:391-397, 2003.
11. Fraser WD, Taggart DP, Fell GS, et al: Changes in iron, zinc and cooper concentrations in serum and in their binding to transport proteins after cholecystectomy and cardiac surgery. Clin Chem 35:2243-2247, 1989.
12. Upchurch GR, Keagy BA, Johnson G: An acute-phase reaction in diabetic patients with foot ulcers. Cardiovasc Surg 5:32-36, 1997.
13. van Iperen CE, Kraaijenhagen RJ, Biesma DH, et al: Iron metabolism and erythropoiesis after surgery. Br J Surg 85:41-45, 1998.
14. Schwartz JA, Keagy BA, Jhonson G: Effect of the acute phase reaction on blood viscosity after infrainguinal arterial bypass. Am J Surg 152:158-164, 1986.
15. Galle C, Maertelaer V, Motte S, et al: Early inflammatory response after elective aortic aneurysm repair: A comparison between endovascular procedure and conventional surgery. J Vasc Surg 32:234-246, 2000.
16. Rowlands TE, Homer VS: Pro- and anti-inflammatory cytokine release in open versus endovascular repair of abdominal aortic aneurysm. Br J Surg 88: 1335-1340, 2001.
17. Bown MJ, Nicholson ML, Bell PRF, et al: The systemic inflammatory response syndrome, organ failure, and mortality after abdominal aortic aneurysm repair. Vasc Surg 37:600-606, 2003.
18. Swartbol P, Truedsson L, Norgren L: The inflammatory response and its consequence for the clinical outcome following aortic aneurysm repair. Eur J Vasc Endovasc Surg 21:393-400, 2001.
19. Haupt W, Hohenberger W, Mueller R, et al: Association between preoperative acute-phase response and postoperative complications. Eur J Surg 163:39-44, 1977.
20. Bellamy MC, Gedney JA: Unrecognised iron deficiency in critical illness. Lancet 352:1903, 1998.
21. Means RT: Recent developments in the anemia of chronic disease. Curr Hematol Rep 2:116-121, 2003.
22. Means RT, Krantz SB: Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 80:1639-1647, 1992.
23. Bohmer F, Fruhwald T, Lapin A: Soluble transferrin receptor and iron status in elderly patients. Wein Med Wochenschr 153:232-236, 2003.
24. Mast AE, Blinder MA, Gronowiski AM, et al: Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clin Chem 44:45-51, 1998.
25. Baillie FJ, Morrison AE, Ferguson I: Soluble transferrin receptor: A discriminating assay for iron deficiency. Clin Lab Haematol 25:353-357, 2003.
26. Kohgo Y, Torimoto Y, Kato J: Transferrin receptor in tissue and serum: Updated clinical significance of soluble receptor. Int J Hematol 76:213-218, 2002.
27. Ponka P, Lok ChN: The transferrin receptor: Role in health and disease. Int J Biochem Cell Biol 31:1111-1137, 1999.
28. Bullen JJ, Ward CG, Rogers CG: The critical role of iron in some clinical infections. Eur J Clin Microbiol Infect Dis 10:613-617, 1991.
29. Jurado RL: Iron, infections and anemia of inflammation. Clin Infect Dis 25:888-895, 1997.
30. van Asbeck BS, Marx JJM, Struyvenberg A, et al: Functional defects in phagocytic cells from patients with iron overload. J Infect 8:232-240, 1984.
31. Herrera JL: Iron depletion is not effective in inducing a virologic response in patients with chronic hepatitis C who failed to respond to interferon therapy. Am J Gastroenterol 94:3571-3575, 1999.
32. Bhaskaram P: Micronutrient, infection, and immunity: An overview. Nutr Rev 60:540-45, 2002.
33. Thurnham DI: Micronutrients and inmune function: Some recent developments. J Clin Pathol 50:887-891, 1997.
34. Cunetti E, Chiari MM, Monti M, et al: Distortion of iron status indices by acute inflammation in older hospitalized patients. Arch Geront Geriatr 39:35-42, 2004.
35. Valth B, Marx JJM: Iron, atherosclerosis, and ischemic heart disease. Arch Int Med 159:1542-1548, 1999.
36. Andrews NC: Disorders of iron metabolism. N Engl J Med 341:1986-1995, 1999.
37. Braun S, Ndrepepa G, von Beckerath N, et al: Value of serum ferritin and soluble transferrin receptor for prediction of coronary artery disease and its clinical presentations. Atherosclerosis 174:105-110, 2004.
38. Duffy SJ, Biegelsen ES, Holbrook M, et al: Iron chelation improves endothelial function in patients with coronary artery disease. Circulation 103:2799-2804, 2001.
39. Vernet M: The transferrin receptor: Its role in iron metabolism and its diagnosis utility. Ann Biol Clin 57:9-18, 1999.
40. ten Kate J, Wolthuis A, Westerhuis B, et al: The iron content of serum ferritin: Physiological importance and diagnostic value. Eur J Clin Chem Clin Biochem 35:53-56, 1997.
41. Hansen TM: Serum ferritin and the assessment of iron deficiency in rheumatoid arthritis. Scand J Rheumatol 12:353-359, 1983.
42. Funchs D, Zangerle R, Artner E, et al: Association between inmune activation, changes in iron metabolism, and anemia in HIV infection. Eur J Haematol 50:90-94, 1993.
43. Matzner Y, Konijn AM, Hershko C: Serum ferritin in hematologic malignancies. Am J Hematol 9:13-17, 1980.
44. Pintado T, Perez I, Escudero A, et al: Physiopathology of iron metabolism. Medicine 8:2669-2675, 2001.